ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug
Article content
SASKATOON, Saskatchewan — ZYUS Life Sciences Corporation (the 'Company') (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce it is in the process of finalizing site initiation for the initial locations to be used in its Phase 2 UTOPIA (Unique Treatment of Oncology Pain in Advanced Cancer) clinical trial.
Article content
The Phase 2 UTOPIA clinical trial will consist of Phase 2A ('UTOPIA-1') and Phase 2B ('UTOPIA-2). UTOPIA-1 is a single-arm proof-of-concept study to investigate the safety and preliminary analgesic efficacy of Trichomylin ® softgel capsules in humans with advanced cancer and moderate to severe cancer-related pain. Insights gained from UTOPIA-1 will guide the strategy for UTOPIA-2, which will be a randomized, placebo-controlled trial that will further assess safety and efficacy in a larger patient population.
Article content
Patient enrollment for UTOPIA-1 is expected to begin in early June 2025, across multiple sites in Canada, with interim data from UTOPIA-1 anticipated mid-summer 2025.
Article content
ZYUS' announcement comes at a time of growing global recognition of the untapped potential of cannabinoids in oncology. A meta-analysis of medial cannabis outcomes and associations with cancer published in Frontiers in Oncology on April 14, 2025, analyzed over 10,000 peer-reviewed studies encompassing 39,767 data points. The findings revealed a 'strong consensus' supporting cannabinoids for managing cancer-related symptoms. While researchers highlight the need for further research to assess the full therapeutic potential of cannabinoids, the findings signal a critical shift in the scientific conversation. This emerging body of evidence reinforces the importance of rigorous clinical research, product purity and consistency, and reinforces ZYUS' commitment to advancing evidence-based cannabinoid therapies.
Article content
'As we finalize site initiation for UTOPIA-1, we are proud to advance clinical development of Trichomylin ® softgel capsules,' said Brent Zettl, President and CEO of ZYUS. 'Our research aims to bridge the gap between conventional treatments like opioids and NSAIDs, and deliver an alternative, evidence-based pharmaceutical option for cancer pain. This trial is a pivotal step in our journey to improve patient outcomes and quality of life.'
Article content
ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit www.zyus.com or follow us on X @ZYUSCorp.
Article content
This news release contains 'forward-looking information' within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, use UTOPIA-1 to guide the strategy for UTOPIA-2, begin patient enrollment in June 2025 and obtain interim data respecting UTOPIA-1 by mid-summer 2025. Any such forward-looking statements may be identified by words such as 'expects', 'anticipates', 'intends', 'contemplates', 'believes', 'projects', 'plans', 'will' and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates, introduce products that act as alternatives to current pain management therapies such as opioids, use UTOPIA-1 to guide the strategy for UTOPIA-2 begin patient enrollment in June 2025 and obtain interim data respecting UTOPIA-1 by mid-summer 2025 are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
For more information, please contact:
Article content
ZYUS Media Inquiries
media@zyus.com
1-833-651-7723
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
4 hours ago
- CBC
New study looks at teen loneliness and AI: Dr. Peter Lin
A recent study by Common Sense Media and the University of Chicago asked teens about their use of artificial intelligence. Dr. Peter Lin explains what the study showed and how AI is affecting the mental health of teenagers.
CBC
5 hours ago
- CBC
'Alarmingly low' monarch butterfly population calls for international conservation strategy: Guelph professor
Social Sharing To save the "alarmingly low" population of monarch butterflies in North America, a University of Guelph professor and ecologist says Canada, the U.S., and Mexico need to co-operate on a wide-scale conservation plan. Ryan Norris and his colleagues have studied monarch butterflies in North America and developed a conservation strategy outlined in a paper recently published in the journal Current Biology. "In the last 15 years, [monarch butterfly populations have] been at alarmingly low numbers," Norris told CBC K-W's The Morning Edition guest host Josette Lafleur. "We really need a conservation plan that we can enact now that's coordinated, and gives us the best return on our investment." Monarch butterflies are known for undertaking the longest migration of any known insect species. The butterflies spend the winter in the mountains of central Mexico. Afterwards, they migrate through the U.S. and into Canada, breeding multiple generations along the way. The cycle restarts when the offspring that reach southern Canada head back to Mexico around the end of summer. Role in the ecosystem Monarch butterflies, like most butterflies, are pollinators, Norris says. Pollinators play an important part in the food chain by allowing pollen-producing plants to reproduce effectively. They are also an important food source for a wide variety of animals, which is why Norris says if the butterfly's population dwindles even further, then "we're in big trouble." In 2016, the Committee on the Status of Endangered Wildlife designated the monarch butterfly as endangered. Then in 2023, the Canadian government listed the monarch butterfly as an endangered species under the Species at Risk Act. These designations were given to the butterfly because of declining populations in North America in the last several years. But it's different in the U.S., where the monarch butterfly doesn't have the same designation. Last December, the U.S. Fish and Wildlife Service proposed that the monarch butterfly be added to the list of threatened species under the Endangered Species Act. As of today, it remains a proposal. Wendy Caldwell is executive director at Monarch Joint Venture, a partnership of U.S. federal and state agencies, non-governmental organizations, businesses and academic programs working together to protect the monarch migration across the country. Caldwell says protocol calls for a public comment period of around one year before a ruling can be finalized. Since the proposed rule was issued in December 2024, Caldwell is anticipating a finalized rule around December of this year. With the ruling still pending, she told CBC News they're doing everything in their power including working with "state and federal agencies, non-profits, businesses, communities, and individuals" in conservation efforts. The proposed strategy In their study, Norris and his fellow researchers tried to answer the question: "Given a set time frame of five years, and a set pot of money that we can use, what's the best course of action to conserve monarch butterflies?" Norris' team developed a five-year plan after inputting everything they knew about monarch butterflies and any constraints they identified. The answer the researchers found was simple — restoring milkweed across Canada, the U.S., and Mexico at specific times of the butterfly's annual cycle. "In the first four years of a plan, the best thing to do is invest money into restoring milkweed, the monarch's host plant, in the U.S. midwest," he said. "Then in the fifth year, allocate some of those resources to restoring milkweed in Ontario and the Canadian provinces, and then some resources into protecting habitat in Mexico for their overwintering sites." Milkweed, as the name suggests, is a type of weed that people and farmers often try to remove from their farms. However, milkweed is the only food source for the monarch butterfly caterpillars, which is why the conservation plan focuses on planting milkweed in areas where monarchs lay eggs during specific times of the year. This strategic investment is something that Donald Davis, a member of the Toronto Entomology Association and chair of the Monarch Butterfly Fund, wholeheartedly agrees with, especially here in Canada. "[The proposal] is correct to focus on priority areas, which for Canada would include southern Quebec and Ontario," he said. Davis has been tagging monarch butterflies since 1967, and continuously since 1985. He says that by focusing on areas where monarchs actually pass through during their migration, it's like getting "the biggest bang for the buck." Now, despite the proposal focusing on strategic planting of milkweed along the monarchs' migration path, Norris said that pulling off such a plan will still require significant finding — a minimum funding of $30 million a year, or $150 million for five years. He says the steep price tag is because the plan spans three countries. International co-operation and co-ordination Caldwell says that since the 1980s, the U.S., Canada, and Mexico have been working together to protect monarch populations throughout their migratory range. She says the Monarch Joint Venture recognizes the reality that the survival of monarch butterflies "depends on healthy habitats across all three countries." In the U.S., efforts to preserve and improve monarch butterfly populations are taking place across the country, and Caldwell says the Monarch Joint Venture is in the middle of many of these efforts — from conducting community science and research programs to tracking populations and habitat conditions. "We also engage the broader public in every aspect of this work — from participating in community science to planting native milkweed and nectar plants across backyards, communities, working lands, and larger landscapes," she said. But trying to coordinate a multi-country conservation plan between Canada, the U.S., and Mexico is more complicated than it looks. Norris says there are "some troubling things" happening in the U.S. that's going to prevent conservation efforts from being administered effectively. Throughout 2025, the U.S. government has cut billions of dollars in funding from scientific research as part of sweeping cost-cutting measures. "It's going to set back conservation … a number of decades, unfortunately," Norris said. Still, Norris believes there is an existing structure for collaboration, referring to the Commission on Environmental Co-operation, which has been around for a number of years. Monarch butterflies have been listed as an endangered species in Canada due to the growing decline in their population over the years. Ryan Norris, an associate professor and ecologist at the University of Guelph, says there is a way to save them but it would require the help of the U.S. and Mexico to do so. According to the commission's website, its objectives include "facilitating cooperation and public participation to foster conservation, protection and enhancement of the North American environment for the benefit of present and future generations, in the context of increasing economic, trade and social links between the three countries." "I mean it's not a great time (for collaboration) ... but maybe somewhat ironically, it is a good time at something we can co-operate on and do," Norris said. What you can do Davis has good news amidst the monarch's bleak situation. He says many residents of Ontario have shown interest in monarch butterflies, and that they are "already contributing to the population recovery." Similarly, Norris says he's been seeing more properties planting milkweed and native flowers, which he calls "a really valuable tool to maintain urban biodiversity." He's urging people to continue doing this because it not only benefits the monarchs, it also benefits other native pollinators. This effort seems to be growing across the country. In New Brunswick, several municipalities have put up milkweed plants or gardens. The goal of these gardens is to help "young caterpillars prepare for their more than 4,000-kilometre overwintering journey to Mexico." Caldwell says a lot more effort is needed to secure a sustainable future for monarch butterflies. "Expanding large-scale habitat restoration and long-term monitoring — especially on working and public lands — is critical," she said. "Stronger collaboration across sectors and borders is essential, as monarchs rely on healthy habitats throughout their migratory range." Norris says he believes all countries involved have the ability to do it. "Do we have the will to do it? I'm not sure."
CBC
5 hours ago
- CBC
Why it's funny/not funny that I have to jump through hoops to get medical equipment
Social Sharing This First Person article is the experience of Alex Lytwyn, who lives with cerebral palsy and is a disability advocate, writer and small business owner of Willpower Media. For more info rmation about CBC's First Person stories, please see this FAQ. You can read more First Person articles here. For people who have mobility issues, it seems counterintuitive — and almost comical — that physically disabled citizens often have to jump through a lot of governmental hoops to access things that could improve their lives. When a person who has a physical disability and is on income assistance needs a medical device, it is an extremely long process to get one. Any medical equipment you may need has to be requested through a branch of government called DHSU (disability and health supports unit). That's not as easy as it sounds. First, an OT (occupational therapist) has to meet with you and evaluate your need for the equipment. Then, they have to make a report about how this piece of equipment will benefit your life and send it to the DHSU. It's important to keep in mind that the person reviewing the equipment request has no real idea why or how this piece of equipment will enhance your life. I think they're concerned with how much it will cost. After that, it can take months for the department to make a decision. If the equipment request gets denied, it's damaging on multiple levels. It hurts because you do not get the much-needed equipment and it hurts because you know that life — instead of getting a little bit easier — will continue to remain difficult. I have been denied what I consider life-improving equipment, because the person reviewing the file does not think it will be useful to me. How the heck does that person have any idea about my life or the equipment? For example, when I get a new power chair, it does not come with a backrest or seating. Both of these items need to be applied for through DHSU, which means I actually have to make a special request for them. Naturally, my occupational therapist applies for the backrest and seating that is best for me and my posture habits. But if my application is denied, the only option for me is to get something that's not suitable for me or my posture, meaning the 12 to 13 hours a day that I spend in the power chair will be much, much more uncomfortable. Clear and concise request writing is key when it comes to asking for medical equipment. The OT has to write a report that will make the person who's reading the request feel the need for the equipment. Over the years, all my occupational therapists have been awesome. They go back and forth, often writing multiple reports for the same item. They have countless phone conversations with the provincial department, arguing on my behalf. This all takes a ton of time and a lot of back and forth. Sometimes it works and sometimes it does not. Now sure, there are times when the written word can go a long way in understanding a need. But when it comes to disabilities and medical equipment, seeing how the equipment would benefit the individual would help. This could be done in person or virtually. They need to see for themselves — first-hand — why this equipment is needed. Living with a complex disability comes with enormous challenges. It's a shame that sometimes it feels like the government seems intent on adding to these challenges, instead of helping clear a path to a successful life.
